Seedo Announces Filing for New Artificial Intelligence Patent and Manufacturing of Over 1,800 Units in the Second Quarter – iCrowdNewswire
Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Apr 15, 2019 2:41 AM ET

Seedo Announces Filing for New Artificial Intelligence Patent and Manufacturing of Over 1,800 Units in the Second Quarter


iCrowd Newswire - Apr 15, 2019

TEL AVIV, Israel,– Seedo Corp., “Seedo” (OTCQB:  SEDO), a high-tech company providing the world’s first fully automated and controlled indoor growing machine for the pesticide-free agricultural and vertical farming markets, announced today that it will manufacture more than 1,800 home cultivator units in the second quarter. The company is also announcing the filing for a new patent to cover the artificial intelligence and data analytic algorithms of Eroll Grow Tech’s (Seedo) unique growing agriculture database. The patent covers technology that increases yield, improves the plant feeding process, provides real-time recovery algorithms and detects issues.

“We are excited to move forward with developing Seedo’s agriculture database, which will provide cultivators with unprecedented information about precise growing conditions,” said Seedo CEO Zohar Levy. “The team at Seedo is working hard to bring the most sophisticated home growing solution to market and we’re thrilled to announce our manufacturing increase this quarter.”

Seedo’s airtight system is the world’s first fully automated and controlled indoor growing machine for home-grow and commercial hemp, herbs and vegetables to cost-effectively generate high yields of lab-grade, pesticide-free product. The Seedo solution minimizes cultivation costs by delivering maximum daylight illumination, built-in carbon filters, automated air conditioning, and a smart post-harvest drying system to users. Even in the harshest environments or with limited space, cultivators can use Seedo’s intelligent technology to harvest the next generation of precision agriculture. This software-driven technology will be extended to large-scale farming solutions, including vertical farming, where yields may be significantly greater than traditional farming. Additionally, with the Seedo growing system, seasons and weather conditions will not impact growing patterns or yields.

As part of Seedo’s recent momentum, the company announced a partnership with Kibbutz Dan in Northern Israel to establish the first fully automated, commercial-scale, pesticide-free containerized cannabis farm in Israel. The company also recently established a medical cannabis farm in Moshav Brosh, Israel and raised $4 million in capital, spearheaded by SodaStream CEO Daniel Birnbaum, who recently joined the company’s board of directors.

About Seedo

Seedo is a market leading high-tech company providing the hemp and agriculture industries with the world’s first fully automated and controlled indoor growing machine. Seedo provides growers with the freedom to cut costs while generating high yields of lab-grade, pesticide-free herbs and vegetables. Seedo’s AI-powered, turnkey systems enable anyone from average consumers to large-scale producers the ability to grow without prior experience or ample space. Seedo is a publicly traded company backed by a group of international investors including Cannabics Pharmaceuticals and is headquartered in Israel. For more information, visit http://www.seedolab.com

Disclaimer:

Certain statements contained in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Such statements include, but are not limited to statements identified by words such as “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “targets,” “projects” and similar expressions.  The statements in this release are based upon the current beliefs and expectations of our company’s management and are subject to significant risks and uncertainties.  Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, the effect of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, potential litigation by or against us, any governmental review of our products or practices, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our latest Form 10-K Report filed on January 15th, 2019.  We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time.

Contact Information:

Seedo Corp.
+972-546-642-228
General Information: [email protected]








Tags:    Wire, Disclosure Newswire, Europe, English